🕒 Thursday 13 February 2025 Thu, 13 Feb 2025

Pure Foods Tasmania Limited (ASX: PFT) will recommence trading on the ASX from 14 February 2025 following the lifting of its suspension after submitting reissued financial statements with an unqualified audit opinion.

Unibail-Rodamco-Westfield delivered robust FY-2024 results with a 7% rise in like-for-like EBITDA and adjusted recurring EPS surpassing guidance, supported by strong retail and convention business performance. The company also announced a 40% increase in its proposed dividend, reflecting confidence in its financial health and strategic asset management.

Ten Sixty Four Limited has successfully exited external administration following the full effectuation of its Deed of Company Arrangement, marking a pivotal step toward resuming normal operations and ASX trading.

Pure Foods Tasmania has executed key loan extensions with Commonwealth Bank and outlined a comprehensive turnaround strategy to address its financial challenges, despite ongoing material uncertainty over its going concern status.

Embelton Limited has announced a fully franked ordinary dividend of AUD 0.15 per share for the six months ending December 2024, signaling steady shareholder returns.

Embelton Limited reported a notable 25.4% decline in revenue for the half-year ended December 31, 2024, yet managed a 23% increase in net profit, underscoring effective cost controls amid a challenging construction market. The company declared an interim dividend consistent with the prior period, signaling confidence despite subdued outlook.

Evolution Mining Limited has announced a fully franked ordinary dividend of AUD 0.07 per share for the half-year ending December 2024, accompanied by a Dividend Reinvestment Plan offering a 5% discount.

Delta Lithium has revealed significant progress in its Western Australian lithium and gold assets, underpinned by robust resource estimates and ongoing exploration. The company’s strategic focus on capital discipline and monetising gold positions it well for future growth.

Desane Group Holdings has secured a lease extension with Brisbane City Council for its Wacol industrial property, guaranteeing $4.5 million in rental income through to 2030. This deal underscores confidence in Desane’s strategic positioning in Brisbane’s industrial market.

Micro-X Ltd has secured a $6 million contract extension from the U.S. Department of Homeland Security to develop and test additional self-screening airport security checkpoints, marking a significant step forward in its innovative security technology program.

Hancock & Gore Limited (ASX: HNG) showcased a transformative year at its 121st AGM, spotlighting a strategic merger with Schoolblazer that creates a leading global uniforms platform and signals a new phase of growth and portfolio simplification.

Tivan Limited has accelerated development of its Sandover Fluorite Project in the Northern Territory, unveiling ultra high-grade assay results and a detailed exploration and approvals program targeting drilling in late 2025.

Prophecy International Holdings has posted a record half-year revenue of $11.6 million for H1 FY25, driven by strong demand for its AI-enabled cybersecurity and data integration products. The company’s transition to subscription models and expansion into new global markets underpin a positive outlook.

Bravura Solutions Limited has announced an ordinary and special dividend totaling AUD 0.1052 per share for the financial year ending December 2024, signaling steady shareholder returns despite an unfranked payout.

Citigroup Global Markets Australia has announced a fully franked AUD 2.25 dividend for CBA CitiFirst Instalments, with trading turning ex-dividend on 19 February 2025. This aligns with the CBA Ordinary Security dividend schedule, offering investors synchronized payout timing.

Citigroup Global Markets Australia confirms a fully franked AUD 2.25 dividend for CBA CitiFirst Instalment MINIs, aligning key dates with CBA ordinary shares.

Recce Pharmaceuticals has temporarily paused trading of its securities, signaling a potentially significant development pending further disclosure.

Pro Medicus has delivered a record first half in FY25, driven by strong revenue growth, major contract wins, and successful implementations that position it well for future expansion.

VHM Limited has unveiled a staged development plan for its Goschen Rare Earths and Mineral Sands Project, targeting first production by late 2026 and a scalable expansion to 5Mtpa by 2029 with robust financial returns.

Krakatoa Resources has provided a detailed update on its Zopkhito Antimony-Gold Project in Georgia, revealing significant exploration data and a strategic plan to advance towards JORC-compliant resources.

Australian Rare Earths Limited confirms uranium mineralisation in initial drilling at its expansive Overland Project, validating its geological model and highlighting potential for cost-effective ISR mining.

Althea Group Holdings has sharply downgraded its FY25 financial guidance, citing significant challenges in its medicinal cannabis division and the strategic withdrawal from a vape product initiative. Despite the setback, the company highlights ongoing growth in its recreational cannabis operations and a strategic refocus on capital efficiency.

Neurotech International has inked a development deal with RH Farma to produce a pharmaceutical-grade cannabinoid drug targeting pediatric neurodevelopmental disorders, leveraging advanced European extraction technology.

Bounty Oil & Gas, through its joint venture operator Asset Energy, has initiated a judicial review against the refusal to vary and extend the PEP-11 offshore petroleum exploration permit. The legal challenge could reshape the future of this key Sydney Basin asset.